Sort   by:  
 Page size 
UnknownSafety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents.
Not available
S-EPMC8174030 | biostudies-literature
UnknownA Bivalent Omicron-BA.4/BA.5-Adapted BNT162b2 Booster in ≥12-Year-Olds.
Not available
S-EPMC11093671 | biostudies-literature
UnknownSafety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months.
Not available
S-EPMC8461570 | biostudies-literature
UnknownSafety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine.
Not available
S-EPMC9006787 | biostudies-literature
UnknownEfficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico.
Not available
S-EPMC8693692 | biostudies-literature
UnknownSafety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
Not available
S-EPMC7745181 | biostudies-literature
UnknownSafety, Immunogenicity, and Efficacy of the NVX-CoV2373 COVID-19 Vaccine in Adolescents: A Randomized Clinical Trial.
Not available
S-EPMC10536880 | biostudies-literature
UnknownRisk of COVID-19 after natural infection or vaccination.
Not available
S-EPMC10518569 | biostudies-literature
UnknownClinical and Demographic Factors Associated With COVID-19, Severe COVID-19, and SARS-CoV-2 Infection in Adults: A Secondary Cross-Protocol Analysis of 4 Randomized Clinical Trials.
Not available
S-EPMC10346130 | biostudies-literature
UnknownSARS-CoV-2 Viral Load in the Nasopharynx at Time of First Infection Among Unvaccinated Individuals: A Secondary Cross-Protocol Analysis of 4 Randomized Trials.
Not available
S-EPMC11117088 | biostudies-literature
Sort   by:  
 Page size